Comparison of three different types of cilostazol-loaded solid dispersion: Physicochemical characterization and pharmacokinetics in rats

Colloids Surf B Biointerfaces. 2017 Jun 1:154:89-95. doi: 10.1016/j.colsurfb.2017.03.017. Epub 2017 Mar 9.

Abstract

The aim of this research was to compare three different types of cilostazol-loaded solid dispersion system including solvent-evaporated, solvent-wetted and surface-attached solid dispersion. The effect of polymers and surfactants on the aqueous solubility of cilostazol was investigated, leading to the selection of polyvinylpyrrolidone (PVP) and sodium lauryl sulphate (SLS). Employing a spray-drying technique, numerous surface-attached, solvent-evaporated and solvent-wetted solid dispersions were prepared with various amounts PVP and SLS using water, 90% ethanol and acetone, respectively. Their physicochemical properties, solubility, dissolution and oral bioavailability in rats were assessed compared to the drug powder. Among each solid dispersion system tested, the surface-attached, solvent-evaporated and solvent-wetted solid dispersions composed of cilostazol, PVP and SLS at weight ratios of 3.0 : 0.75 : 1.5, 3.0 : 3.0 : 1.5 and 3.0 : 3.0 : 1.5, respectively, provided the highest drug solubility and dissolution. The solvent-evaporated solid dispersion gave homogeneous and very small spherical particles, in which the drug was changed to an amorphous state. In the solvent-wetted solid dispersion, the amorphous drug was attached to the polymer surface. Conversely, in the surface-attached solid dispersion, the carriers were adhered onto the surface of the unchanged crystalline drug. The solubility, dissolution and oral bioavailability were significantly increased in the order of solvent-evaporated>solvent-wetted>surface-attached>drug powder. Thus, the type of solid dispersion considerably affected the physicochemical properties, aqueous solubility and oral bioavailability. Furthermore, the cilostazol-loaded solvent-evaporated solid dispersion with the highest oral bioavailability would be actively recommended as a practical oral pharmaceutical product.

Keywords: Cilostazol; Crystallinity; Oral bioavailability; Solubility; Solvent-evaporated solid dispersion; Solvent-wetted solid dispersion; Surface-attached solid dispersion.

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Animals
  • Biological Availability
  • Chemical Phenomena
  • Cilostazol
  • Drug Carriers / chemistry
  • Drug Compounding / methods
  • Male
  • Microscopy, Electron, Scanning
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / blood
  • Platelet Aggregation Inhibitors / pharmacokinetics
  • Powders
  • Rats
  • Rats, Sprague-Dawley
  • Solubility
  • Solvents
  • Surface Properties
  • Surface-Active Agents
  • Tetrazoles / administration & dosage*
  • Tetrazoles / blood
  • Tetrazoles / pharmacokinetics*
  • Water

Substances

  • Drug Carriers
  • Platelet Aggregation Inhibitors
  • Powders
  • Solvents
  • Surface-Active Agents
  • Tetrazoles
  • Water
  • Cilostazol